Carl V. Leier

Q: What Schools Are Affiliated With Carl V. Leier

Carl V. Leier is affiliated with the following schools: Ohio State University, Duke University

Carl V. Leier's AcademicInfluence.com Rankings

Carl V. Leier

Engineering

#5913

World Rank

#7200

Historical Rank

Biomedical Engineering

#479

World Rank

#489

Historical Rank

engineering Degrees

Carl V. Leier

Philosophy

#8107

World Rank

#11427

Historical Rank

Logic

#5140

World Rank

#6512

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Carl V. Leier's Degrees

Doctorate Medicine Stanford University

Why Is Carl V. Leier Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Carl V. Leier's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness (2005) (966)
Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). (1995) (684)
Factors influencing the one-year mortality of dilated cardiomyopathy. (1984) (556)
Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure (2000) (476)
Comparative Systemic and Regional Hemodynamic Effects of Dopamine and Dobutamine in Patients with Cardiomyopathic Heart Failure (1978) (409)
Consensus recommendations for the management of chronic heart failure: Introduction (1999) (391)
Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors (2010) (370)
Remodeling and reparation of the cardiovascular system. (1992) (341)
Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. (1990) (317)
Improved Exercise Capacity and Differing Arterial and Venous Tolerance During Chronic Isosorbide Dinitrate Therapy for Congestive Heart Failure (1983) (302)
Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. (1993) (246)
Tolerance to dobutamine after a 72 hour continuous infusion. (1980) (239)
Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. (2007) (230)
Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. (2010) (221)
Value of Clinician Assessment of Hemodynamics in Advanced Heart Failure: The ESCAPE Trial (2008) (214)
Changes in Diastolic Time with Various Pharmacologic Agents: Implication for Myocardial Perfusion (1979) (204)
Prolonged Atrial Conduction: A Major Predisposing Factor for the Development of Atrial Flutter (1978) (203)
Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. (1994) (182)
Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. (1984) (175)
Drugs five years later. Dobutamine. (1983) (174)
Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure. (2000) (171)
Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. (1986) (169)
Cardiovascular abnormalities associated with adult polycystic kidney disease. (1984) (162)
The spectrum of cardiac defects in the Ehlers-Danlos syndrome, types I and III. (1980) (159)
Changing preferences for survival after hospitalization with advanced heart failure. (2008) (142)
The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy. (1983) (139)
The arrhythmogenic effects of caffeine in human beings. (1983) (134)
Long-term benefit of dobutamine in patients with congestive cardiomyopathy. (1980) (131)
Parenteral inotropic support for advanced congestive heart failure. (1998) (123)
Human myocardial histologic characteristics in congestive heart failure. (1983) (121)
Drug-induced conditioning in congestive heart failure. (1982) (112)
Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors. (2012) (111)
Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study. (1984) (108)
Regional blood flow responses to vasodilators and inotropes in congestive heart failure. (1988) (106)
Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin and nitroprusside in patients with congestive heart failure. (1981) (106)
Assessment of Left Ventricular Pressure‐Volume Relations Using Gated Radionuclide Angiography, Echocardiography, and Micromanometer Pressure Recordings: A New Method for Serial Measurements of Systolic and Diastolic Function in Man (1983) (105)
Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trial. (2007) (102)
Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation. (1998) (100)
Cocaine-induced coronary-artery dissection. (1994) (98)
Dobutamine pharmacokinetics in severe heart failure (1978) (97)
Cardiovascular pharmacology of dopexamine in low output congestive heart failure. (1988) (96)
Captopril in Primary Pulmonary Hypertension (1983) (95)
The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy. (1983) (91)
Altered collagen composition in a prolapsing mitral valve with ruptured chordae tendineae. (1979) (88)
Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure. (1989) (82)
Clonidine in congestive heart failure: a vasodilator with negative inotropic effects. (1983) (81)
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America. (2000) (81)
Cardiac function in Duchenne's muscular dystrophy. Results of 10-year follow-up study and noninvasive tests. (1982) (80)
Cardiovascular effects of ophthalmic timolol. (1986) (79)
Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension. (1982) (78)
Survival in congestive heart failure during treatment with drugs with positive inotropic actions. (1987) (78)
Influence of positive inotropic therapy on pulsatile hydraulic load and ventricular-vascular coupling in congestive heart failure. (1990) (69)
Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow. (1984) (67)
Recovery of normal ventricular function in patients with dilated cardiomyopathy: predictors of an increasingly prevalent clinical event. (2008) (65)
Fatal Hemorrhage as a Complication of Neurofibromatosis (1972) (63)
The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failure. (1979) (61)
Development of pharmacodynamic tolerance to prozosin in congestive heart failure. (1979) (61)
Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure. (1980) (60)
Hemodynamic changes after meals and placebo treatment in chronic congestive heart failure. (1986) (60)
An analysis of the determinants of exercise performance in congestive heart failure. (1987) (59)
High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomization. (2008) (58)
Effect of Increased Adrenergic Activity on the Relationship Between Electrical and Mechanical Systole (1981) (58)
Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose. (1981) (55)
Detection of coronary artery disease in orthotopic heart transplant recipients with 64-detector row computed tomography angiography. (2006) (55)
Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated cardiomyopathy. (1983) (54)
Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study. (1980) (54)
Atrial fibrillation in mitral stenosis: histologic, hemodynamic and metabolic factors. (1984) (54)
Beneficial effects of nifedipine on rest and exercise myocardial energetics in patients with congestive heart failure. (1984) (53)
Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients. (2000) (53)
The Dopamine Congener, Ibopamine, in Congestive Heart Failure (1984) (51)
DOXORUBICIN CARDIOTOXICITY (1982) (50)
Prevention of bedrest-induced physical deconditioning by daily dobutamine infusions. Implications for drug-induced physical conditioning. (1985) (49)
Early changes in human myocardial nuclei after doxorubicin (1983) (45)
Interatrial conduction (activation) times. (1979) (43)
Regression of myocardial cellular hypertrophy with vasodilator therapy in chronic congestive heart failure associated with idiopathic dilated cardiomyopathy. (1983) (41)
Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs. (1985) (37)
Placebo treatment in congestive heart failure. (1992) (37)
The pharmacokinetics of midazolam in patients with congestive heart failure. (1990) (36)
Alpha-adrenergic component of the sympathetic nervous system in congestive heart failure. (1990) (36)
Hemodynamic-inotropic response to beta-blocker with intrinsic sympathomimetic activity in patients with congestive cardiomyopathy. (1986) (35)
Clinical and regulatory implications of the Cardiac Arrhythmia Suppression Trial. (1990) (35)
Depressed aerobic enzyme activity of skeletal muscle in severe chronic heart failure. (1991) (35)
Attempt to prevent doxorubicin-induced acute human myocardial morphologic damage with acetylcysteine. (1983) (34)
Aorto-left atrial fistula. A reversible cause of acute refractory heart failure. (1997) (33)
Diastolic time in congestive heart failure. (1987) (33)
The effect of age on central and regional hemodynamics. (1984) (33)
Triple AV nodal pathways in man? (1980) (32)
Effects of Hydralazine on Coronary Blood Flow and Myocardial Energetics in Congestive Heart Failure (1982) (31)
The effect of left atrial histology and dimension on P wave morphology. (1983) (30)
Hemodynamic and metabolic responses of the exercising lower limb of humans. (1987) (30)
Regional blood flow in human congestive heart failure. (1992) (30)
Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug. (1984) (29)
Dobutamine and hydralazine: comparative influences of positive inotropy and vasodilation on coronary blood flow and myocardial energetics in nonischemic congestive heart failure. (1983) (29)
Serum and tissue magnesium concentrations in patients with heart failure and serious ventricular arrhythmias. (1990) (29)
Central and regional hemodynamic effects of flosequinan for congestive heart failure. (1989) (29)
HFSA guidelines for the management of patients with heart failure due to left ventricular systolic dysfunction--pharmacological approaches. (2000) (28)
The arrhythmogenic effects of caffeine in human beings (1983) (28)
The noninvasive localization of ventricular pacing sites by radionuclide phase imaging. (1984) (27)
Current status of non-digitalis positive inotropic drugs. (1992) (27)
Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial. (2007) (26)
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination. (2001) (26)
The Anatomic Relationship of the Esophageal Lead to the Left Atrium (1982) (26)
Dobutamine Increases Cardiac Output of the Total Artificial Heart: Implications for Vascular Contribution of Inotropic Agents to Augmented Ventricular Function (1991) (25)
Biochemical and histologic correlates of ventricular end-diastolic pressure. (1981) (25)
Increased Diastolic Time: A Possible Important Factor in the Beneficial Effect of Propranolol in Patients with Coronary Artery Disease (1979) (25)
Autonomic tone of patients during an electrophysiological catheterization. The role of autonomic influences on the reproducibility of sinus node function studies. (1980) (23)
In vivo validation of the origin of the esophageal electrocardiogram. (1986) (23)
The Shortcomings of Clinical Practice Guidelines (2015) (23)
Hemodynamic effects of smoking in congestive heart failure. (1988) (23)
Y-box binding protein-1 implicated in translational control of fetal myocardial gene expression after cardiac transplant (2012) (22)
The evolution of beta-adrenergic dysfunction during the induction of canine cobalt cardiomyopathy. (1984) (22)
The efficacy of N-acetylcysteine in preventing doxorubicin-induced cardiomyopathy in dogs. (1983) (22)
The effect of vasodilator therapy on systolic and diastolic time intervals in congestive heart failure. (1982) (22)
Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy. (2012) (21)
The physical examination in heart failure--Part I. (2007) (21)
Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study. (1988) (21)
Disparity between improvement in left ventricular function and changes in clinical status and exercise capacity during chronic enoximone therapy. (1989) (21)
Time intervals of cardiac resynchronization therapy in heart failure. (2004) (21)
Differentiating characteristics of myocardial nuclei in cardiomyopathy. (1983) (21)
Hydralazine therapy in chronic congestive heart failure. Sustained central and regional hemodynamic responses. (1984) (21)
Usefulness of hydralazine to withdraw from dobutamine in severe congestive heart failure. (1991) (20)
Hemodynamic effects of oral nicorandil in congestive heart failure. (1990) (20)
Electrolyte disturbances in chronic heart failure: Metabolic and clinical aspects (1995) (20)
Comparison between electrophysiologic studies and ambulatory monitoring in patients with syncope. (1983) (19)
Regional Hemodynamic Effects of Clonidine in Congestive Heart Failure (1985) (19)
Biatrial electrograms during coarse atrial fibrillation and flutter-fibrillation. (1980) (19)
Noninvasive profile in the prospective monitoring of adriamycin cardiomyopathy. (1978) (19)
Electrophysiologic studies of perphenazine and protriptyline in a patient with psychotropic drug-induced ventricular fibrillation. (1979) (19)
Long-term indoramin therapy in congestive heart failure: a double-blind, randomized, parallel placebo-controlled trial. (1987) (19)
Biochemical measurements of endomyocardial biopsies. (1981) (19)
Aging of the human myocardium: a histologic study based upon endomyocardial biopsy. (1986) (19)
Hemodynamic effects of intravenous butopamine in congestive heart failure (1980) (17)
Dobutamine-induced eosinophilia. (2004) (17)
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 1--the medical history. (2001) (17)
The physical examination in heart failure--Part II. (2007) (16)
Effect of afterload on left ventricular performance in experimental animals. Comparison of the pre-ejection period and other indices of left ventricular contractility. (1982) (16)
Rescue bariatric surgery for obesity-induced cardiomyopathy. (2006) (16)
Cardiomyoplasty: is it time to wrap it up? (1996) (16)
Acute positive inotropic intervention: the catecholamines. (1991) (15)
Dissimilar atrial rhythms. A patient with interatrial block. (1977) (15)
Serum response factor neutralizes Pur alpha- and Pur beta-mediated repression of the fetal vascular smooth muscle alpha-actin gene in stressed adult cardiomyocytes. (2008) (15)
Role of the pulmonary artery catheter in diagnosis and management of heart failure. (2011) (15)
General overview and update of positive inotropic therapy. (1986) (14)
Human and canine ventricular vasoactive intestinal polypeptide: decrease with heart failure. (1986) (14)
Influence of exercise on coronary sinus blood flow determinations. (1987) (14)
Relationship of cardiac magnetic resonance imaging and myocardial biopsy in the evaluation of nonischemic cardiomyopathy. (2013) (14)
Persistent left superior vena cava: unusual wave contour of left jugular vein as the presenting feature. (1990) (14)
A preliminary report of the effects of orally administered enoximone on regional hemodynamics in congestive heart failure. (1987) (14)
Temporary atrial standstill. (1979) (14)
The effects of ibopamine on cardiovascular and renal function in normal human subjects (1983) (13)
Usefulness of the systolic time intervals in cardiovascular clinical cardiology. (1982) (13)
Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure. (2000) (13)
An electrophysiologic study of swallowing-induced tachycardia. (1978) (13)
Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and14C-disopyramide (1984) (13)
Electrophysiologic mechanisms of provoked atrial flutter in mitral valve prolapse syndrome. (1985) (12)
Metastatic melanoma of the left ventricle: Cardiac imaging in the diagnosis and surgical approach (2004) (12)
Canine cobalt cardiomyopathy: a model for the study of heart failure. (1983) (12)
Reproducibility of systolic and diastolic time intervals in normal humans: an important issue in clinical cardiovascular pharmacology. (1989) (12)
The electrophysiologic effects of upright posture. (1984) (11)
Elevated left ventricular filling pressure as a cause of angina in patients with normal coronary arteries (1982) (11)
Increased ventricular contractility is not sufficient for effective positive inotropic intervention. (1996) (11)
Determination of pindolol in human plasma and urine by high-performance liquid chromatography with ultraviolet detection. (1986) (11)
Augmentation of diastolic function with phosphodiesterase inhibition in congestive heart failure. (1989) (11)
A paucity of chronic electrocardiographic changes with adriamycin therapy. (1978) (11)
Renal roadblock in managing low output heart failure. (2004) (10)
Advancing immunosuppression therapy to counter the progression of cardiac allograft vasculopathy. (2005) (10)
Chronic vasodilator therapy with flosequinan in congestive heart failure (1990) (10)
Heart block in alcoholic cardiomyopathy. (1974) (9)
Electroanatomic and electrographic characterization of atrial flutter following cardiac transplantation: pre- and post-ablation. (2004) (9)
The Problem of Ventricular Dysrhythmias and Sudden Death Mortality in Heart Failure: The Impact of Current Therapy (2000) (9)
Electrophysiologic and Antiarrhythmic Effects of Nitroglycerin in Man (1981) (9)
Invasive hemodynamic monitoring the aftermath of the ESCAPE trial. (2007) (9)
Neurohumoral profile in congestive heart failure: response to beta-blockade. (1988) (9)
Role of the pulmonary artery catheter in diagnosis and management of heart failure. (2009) (9)
Positive inotropic therapy: an update and new agents. (1996) (9)
Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study. (1984) (8)
Cardiotonic drugs: A clinical survey (1986) (8)
Conversion of Atrial Flutter: Rapid Atrial Pacing as a Bedside Technique (1980) (8)
Prolonged electrical systole and QT>QS2 secondary to coronary artery disease (1985) (8)
Treatment of end-stage cardiac failure with dobutamine (1976) (8)
Clinical pharmacology of nicorandil in patients with congestive heart failure (1992) (7)
The TPA controversy and the drug approval process. The view of the Cardiovascular and Renal Drugs Advisory Committee. (1988) (7)
The role of the autonomic nervous system in patients with sinoatrial and atrioventricular node dysfunction. (1981) (7)
Predictors of inpatient outcomes in hospitalized patients after left heart catheterization. (2009) (6)
Preservation of the end-systolic pressure/end-systolic dimension relation following pindolol in congestive heart failure. (1988) (6)
Dismantling mandates in the treatment of heart failure. (2004) (6)
Postoperative pericarditis following thymectomy for myasthenia gravis. A prospective study. (1983) (6)
Diabetes and heart failure: the role of thiazolidinediones in managing these partners in crime. (2007) (6)
Dose‐ and Time‐Dependent Binding and Kinetics of Pindolol in Patients With Congestive Heart Failure (1986) (6)
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatment. (2002) (6)
Removal from the "waiting list" for heart transplantation: a risk factor for sudden death? (1997) (5)
Hemodynamic effects of vasodilator therapy in severe left heart failure combined with large atrial septal defects. (1982) (5)
30th Bethesda Conference: The Future of Academic Cardiology. Task force 4: faculty. (1999) (5)
Rest and exercise cardiovascular effects of terazosin in congestive heart failure. (1990) (5)
Are hemodynamic parameters predictors of mortality? (2009) (5)
In vivo validation of a thermodilution system designed to measure peripheral blood flow. (1985) (5)
Stenotic aortic and mitral valves in three adult brothers with arthrogryposis multiplex congenita. (2005) (5)
Latent Development of Occlusive Coronary Atherosclerosis as a Cause of Decompensation of Non-Ischemic Dilated Cardiomyopathy (2008) (5)
Acute and chronic isosorbide dinitrate therapy in congestive heart failure: demonstration of improved exercise capacity and differing arterial and venous tolerance during chronic administration. (1983) (5)
Postural influences on the hemodynamic responses to vasodilating drugs in congestive heart failure. (1985) (5)
Evaluation of the Patient with Heart Failure (2001) (4)
Enhanced ventricular ectopy following pindolol: an adverse effect of a beta blocker with intrinsic sympathomimetic activity. (1986) (4)
Examining the jugular vein is never in vain. (2010) (4)
Effects of Commonly Used Cardioactive Drugs on Atrial and Sinoatrial Conduction in Man (1980) (4)
Drug regimens for congestive heart failure. (1980) (4)
Hemodynamic Responses to Indoramin at Rest and During Exercise in Congestive Heart Failure (1987) (4)
Human myocardial mitochondria: size differences in parts of the cell. (1981) (4)
Failure of percutaneous transluminal coronary angioplasty to stimulate platelet and prostaglandin activity. (1985) (4)
Preliminary Observations of Chronic Indoramin Therapy in Congestive Heart Failure (1986) (4)
Serum response factor neutralizes Pur-and Pur -mediated repression of the fetal vascular smooth muscle -actin gene in stressed adult cardiomyocytes (2008) (4)
Combined systolic time intervals and M-mode echocardiography in the evaluation of central hemodynamics in primary pulmonary hypertension. (1984) (4)
Clinical perspective: myocardial perfusion pressure in the age of afterload reduction (2000) (4)
Cardiorenal diseases and disorders (1992) (3)
Reperfusion of the human myocardium by saphenous vein bypass grafts. Biochemical considerations. (1984) (3)
Left ventricular performance during the course of a day and meals in dilated cardiomyopathy and heart failure. (1989) (3)
Selecting a mentor: a guide for residents, fellows, and young physicians. (2011) (3)
Intravenous isosorbide dinitrate in the management of acute hypertension following cardiopulmonary bypass. (1982) (3)
Advanced allograft coronary artery disease: interaction between pre and post-transplant risk factors from a 10-year multi-institutional study (2002) (3)
Latissimus Dorsi Cardiomyoplasty (1998) (3)
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 3--Diagnostic studies: laboratory testing. (2002) (3)
The relationship between drug-induced changes in central and regional hemodynamics in congestive heart failure. (1986) (3)
“A‐wave” liver (1988) (3)
A heart failure specialist’s perspective on cardiac surgery for heart failure (2005) (2)
Catecholamine, Renin-Aldosterone, and Glucoregulatory Responses to Maximal Exercise in Humans: Effects of Prolonged Bedrest (1987) (2)
Panel discussion I: Evaluation and management of chronic heart failure (1993) (2)
Anomalous origin of the left main coronary artery from the pulmonary trunk masquerading as peripartum cardiomyopathy. (1997) (2)
Nitrate tolerance. (1985) (2)
Adenocarcinoma of the lung: pericardial tamponade as the major presenting feature. (1979) (2)
Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure (2005) (2)
Late systolic indices of ventricular function: noninvasive derivation in congestive heart failure. (1988) (2)
Clinical Trial Strategies and Future Challenges in the Investigation of Human Congestive Heart Failure (1993) (2)
The cardiomyopathies: mortality, sudden death, and ventricular arrhythmias. (1992) (2)
Syncope in dental practice. (1989) (2)
TheCardiovascular Effects oftheContinuous Infusion ofDobutamine inPatients withSevere Cardiac Failure (1977) (2)
Heart rate responsiveness after sustained chronotropic stimulation with a beta 1-adrenergic receptor agonist. (1983) (2)
Dobutamine and dopamine--Comparative cardiovascular effects of maintenance doses in severe cardiac failure (1978) (2)
Right ventricular aneurysm: clinical and laboratory features. (1982) (2)
Unstable Heart Failure (2002) (1)
An unexpected paradox: wall shear stress in the aorta is less in patients with severe atherosclerosis regardless of obesity. (2020) (1)
Advanced heart failure: a practical management algorithm and therapeutic options. (2004) (1)
Use of chest wall stimulation to localize and treat pacemaker sensing failure. (1980) (1)
Medical therapy of end-stage congestive and ischemic cardiomyopathy. (1988) (1)
Therapeutic approaches and the role of calcium-sensitizing agents in end-stage congestive heart failure (1999) (1)
Exercise Response to a High Incremental and Low Incremental Treadmill Protocol in Patients With Left Ventricular Dysfunction (1991) (1)
The new inotropic drug, dobutamine. (1981) (1)
Changes in Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of MMPs Plasma Profiles in Stress-Induced Cardiomyopathy (2012) (1)
Pharmacology and therapeutics of congestive heart failure. (1985) (1)
Histologic compaison of allograft myocardium between short- and long-term survivors of human cardiac transplantation. (2000) (1)
The major electrolyte disorders of congestive heart failure (1996) (1)
Dobutamine in the Management of Acute Heart Failure Syndrome (2008) (1)
Dopexamine in cardiorespiratory failure. Commentary on drug research in the critically ill. (1989) (1)
Uncontrolled ventricular rate in atrial fibrillation. A manifestation of dissimilar atrial rhythms. (1979) (1)
Intensive cardiac care : newer pharmacology and techniques, Dallas, Texas, November 11, 1990 (1991) (1)
Intravenous pirbuterol (1982) (1)
HEART RATE VARIABILITY DURING EXERCISE IN HEART FAILURE PATIENTS847 (1997) (1)
Levosimendan rapidly lowers plasma endothelin-1 and TNF-alpha levels in patients with severe heart failure (1999) (1)
Effects of Therapy on Regional Blood Flow in Heart Failure (1991) (1)
with severe cardiac failure The cardiovascular effects of the continuous infusion of dobutamine in patients (2011) (0)
Drugs Five Years Later (2020) (0)
The management of heart failure 5 years hence. (2006) (0)
Myocardial Perfusion and Metabolism in Dilated Cardiomyopathy (1990) (0)
Impact of health insurance and black race on outcome after cardiac transplantation: analysis of the cardiac transplant research database (2003) (0)
Relationship between central hemodynamics and regional bloodflow innormalsubjects andin patients withcongestive heart failure (1984) (0)
Progressive decrease in aortic intimal-medial thickness in the paced canine model of ventricular failure: Evidence for apoptotic vascular remodeling (1999) (0)
Clinical evaluation, laboratory testing, and endomyocardial biopsy in dilated cardiomyopathy (1986) (0)
Society’s self-imposed standards infringe on personal liberty and markedly reduce availability of donor organs; a case for self-directed heart donation (2005) (0)
[Interaction between electrolytes and the neurohumoral system. The clinico-prognostic implications of hyponatremia, hypopotassemia and hypomagnesemia in congestive heart failure]. (1993) (0)
Zatebradine and exercise tolerance. (1996) (0)
The responsiveness of human chronotropic receptors diminishes with chronic stimulation (1982) (0)
Prazosin and Hydralazine in Congestive Heart Failure (2020) (0)
Histostructural analysis of allograft myocardium from short- and long-term survivors of human cardiac transplantation (1999) (0)
Immunosuppressive Therapy to Counter Cardiac Allograft Vasculopathy (2008) (0)
Sustained Reduction in Symptoms Related to Reduction of Filling Pressures during Hospitalization for Heart Failure (2006) (0)
EVALUATION OF DOPPLER ASSESSED ASCENDING AORTIC BLOOD FLOW IN HEART FAILURE DURING EXERCISE (2002) (0)
Positive Inotropic Therapy for Chronic Dilated Cardiomyopathy and Congestive Failure (1990) (0)
Intravenous Nitroglycerin in Myocardial Ischemia and Heart Failure (1993) (0)
P-255 Bronchogenic carcinoma after cardiac transplantation (2005) (0)
Abstract 3760: Genomic Determinants of Recovery of Normal Ventricular Function in Patients with Dilated Cardiomyopathy (2006) (0)
CHAPTER 5 – Recent Innovations in the Pharmacology of Low-Output Congestive Heart Failure (1981) (0)
New catecholamines in clinical cardiovascular medicine. (1980) (0)
Abstract 2560: Reduction of Filling Pressures During Hospitalization Predicts Sustained Reduction in Heart Failure Symptoms (2006) (0)
Recent advances in cardiovascular medicine. (1990) (0)
Ambulatory Inotrope Infusions: The Importance of Historical Perspective. (2018) (0)
Congestive Heart Failure: Evolving a Better Understanding of Therapeutic Regimens (1989) (0)
Peak VO2 as a Predictor of Ambulatory Activity of Daily Living in Patients with Chronic Heart Failure (2009) (0)
Myocardium in Congestive Heart Failure (2005) (0)
Chapter-02 Positive Inotropic Drugs: A Limited but Important Role (2013) (0)
Cardiac allograft vasculopathy: attacking the immunological component (2003) (0)
Dilated cardiomyopathy (2001) (0)
Contents Vol. 119, 2011 (2011) (0)
Coronary Microcirculation Remodelling in Dilated Cardiomyopathy: Another Brick in the Wall (2011) (0)
Arterial Embolization with Cardiomegaly (1989) (0)
Fulminant amyloid cardiomyopathy. (1993) (0)
S . A . HEMODYNAMIC RESPONSES TO DIFFERENT LEVELS OF ALPHA-ADRENERGIC INTERRUPTION IN CONGESTIVE HEART FAILURE (0)
CONGESTIVE HEART FAILURE Human myocardial histologic characteristics in congestive heart failure (2005) (0)
Acute onset of dyspnea following coronary artery bypass surgery. (1986) (0)
HEART FAILURE PROGNOSIS USING CARDIAC POWER OUTPUT (1998) (0)
Angiotensin receptor subtype-1 blockade prevents vascular remodeling in the paced canine model of heart failure (1999) (0)
Abstract P334: Comparative Effectiveness of Left Ventricular Assist Devices as a Bridge to Heart Transplantation (2011) (0)
Bronchogenic carcinoma following cardiac transplantation (2005) (0)
Treatment of Heart Failure (1998) (0)
cV-Adrenergic Component of the Sympathetic Nervous System in Congestive Heart Failure (2005) (0)
CLINICAL COMMUNICATION TO THE EDITOR Rescue Bariatric Surgery for Obesity-induced Cardiomyopathy (2006) (0)
The atrial electrograms of coarse atrial fibrillation and flutter-fibrillation (1978) (0)
The Impact of the AMPD1 Gene Polymorphism on Exercise Capacity in Patients with Chronic Heart Failure (2009) (0)
Pathophysiology: Discussion II (1993) (0)
Prolonged electrical systole and QT greater than QS2 secondary to coronary artery disease. (1985) (0)
Ventricular arrhythmias following intravenous cancer chemotherapy. Arrhythmias and chemotherapy. (1986) (0)
chronic isosorbide dinitrate therapy for congestive heart failure Improved exercise capacity and differing arterial and venous tolerance during (2011) (0)
Evidence of angiotensin II-mediated control of sympathetic activity in dilated cardiomyopathy (1990) (0)
Subject Index, Vol. 45, 1984 (1984) (0)
Complex atrial dysrhythmias in a patient with congestive cardiomyopathy. (1977) (0)
Contents, Vol. 45, 1984 (1984) (0)
CONGESTIVE HEART FAILURE Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure (2005) (0)
International Association of Gerontology / Announcement (1984) (0)
Natural course of large spontaneous pneumothorax. (2005) (0)
Commentary 2 (2012) (0)
Serum response factor neutralizes Pur (cid:1) - and Pur (cid:2) -mediated repression of the fetal vascular smooth muscle (cid:1) -actin gene in stressed adult cardiomyocytes (2008) (0)
A look back at 'the management of heart failure 5 years hence'. (2011) (0)
IDENTIFICATION OF VENTILOTORY THRESHOLD IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION (CHF) DURING PROGRESSIVE EXERCISE AND COMPARISON TO NON CARDIAC DISEASE SUBJECTS (1989) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Carl V. Leier?

Carl V. Leier is affiliated with the following schools:

Carl V. Leier's Academic­Influence.com Rankings

Carl V. Leier's Degrees

Why Is Carl V. Leier Influential?

Carl V. Leier's Published Works

Published Works

What Schools Are Affiliated With Carl V. Leier?

Carl V. Leier's AcademicInfluence.com Rankings